All Comments by Russell Swerdlow

  1. Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation.
  2. Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease.
  3. A Protein-Based Study of Parkinsonism’s Incidence
  4. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
  5. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
  6. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
  7. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.
  8. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration.
  9. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.
  10. Parkinson Pathways Branch Out in Flies and Mice
  11. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.
  12. New Drug Treats Early Parkinson's Symptoms, Similar to Older One